According to the TGCA-GBM dataset, high AGTR1 expression showed significantly lower overall survival (OS) and progression-free survival (PFS) in all GBM patients and shorter overall survival in chemotherapy-treated GBM patients (Figure 2). Here, AGTR1 is linked to glioblastoma.